Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Metabolism: Clinical and Experimental|January 5, 2010
Common polymorphisms of the peroxisome proliferator-activated receptor-gamma (Pro12Ala) and peroxisome proliferator-activated receptor-gamma coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitusMing-Chia Hsieh, Kun-Der Lin, Kai-Jen Tien, et al.
American Journal of Nephrology|November 21, 2007
Chronic kidney disease as a risk factor for coronary artery disease in Chinese with type 2 diabetesMing-Chia Hsieh, Jeng-Yueh Hsiao, Kai-Jen Tien, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 14, 2023
Osteoporosis care after hip fracture: Observation from national health insurance database and fracture liaison servicesChun-Feng Huang, Sheng-Chieh Lin, Ho-Min Chen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 11, 2021
Glycemic Control and Prevention of Diabetic Complications in Low- and Middle-Income Countries: An Expert OpinionPablo Aschner, Gagik Galstyan, Dilek G Yavuz, et al.
Bone|March 21, 2018
Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: A systematic literature review and meta-analysisChih-Hsing Wu, Shih-Te Tu, Yin-Fan Chang, et al.
Diabetes Research and Clinical Practice|January 27, 2016
Glycemic excursions are positively associated with changes in duration of asymptomatic hypoglycemia after treatment intensification in patients with type 2 diabetesJun-Sing Wang, I-Te Lee, Wen-Jane Lee, et al.
Journal of Diabetes|April 5, 2016
Glycemic excursions are positively associated with HbA1c reduction from baseline after treatment with acarbose in patients with type 2 diabetes on metformin monotherapyJun-Sing Wang, I-Te Lee, Wen-Jane Lee, et al.
Clinical Therapeutics|November 15, 2011
Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparisonJun-Sing Wang, Shi-Dou Lin, Wen-Jane Lee, et al.
Primary Care Diabetes|October 1, 2014
Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetesShi-Dou Lin, Shih-Tzer Tsai, Shih-Te Tu, et al.
Primary Care Diabetes|May 1, 2026
Effectiveness and safety of connected solutions among people with type 2 diabetes uncontrolled on oral anti-diabetic drugs: A randomized real-world study on InsultrateChieh-Hua Lu, Chih-Hsun Chu, Horng-Yih Ou, et al.
Pageof 8